DexCom (Germany) Analysis

DC4 Stock  EUR 73.54  0.92  1.24%   
DexCom Inc is overvalued with Real Value of 59.57 and Hype Value of 73.54. The main objective of DexCom stock analysis is to determine its intrinsic value, which is an estimate of what DexCom Inc is worth, separate from its market price. There are two main types of DexCom's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect DexCom's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of DexCom's stock to identify patterns and trends that may indicate its future price movements.
The DexCom stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and DexCom's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

DexCom Stock Analysis Notes

About 100.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings (P/E) ratio of 191.84. DexCom Inc had not issued any dividends in recent years. The entity had 4:1 split on the 13th of June 2022. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DEXCOM INC operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2800 people. To learn more about DexCom Inc call Kevin Sayer at 858 200 0200 or check out https://www.dexcom.com.

DexCom Inc Investment Alerts

DexCom Inc has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 100.0% of the company shares are held by institutions such as insurance companies

DexCom Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 40.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DexCom's market, we take the total number of its shares issued and multiply it by DexCom's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

DexCom Profitablity

DexCom's profitability indicators refer to fundamental financial ratios that showcase DexCom's ability to generate income relative to its revenue or operating costs. If, let's say, DexCom is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, DexCom's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of DexCom's profitability requires more research than a typical breakdown of DexCom's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.

Technical Drivers

As of the 27th of November, DexCom shows the Mean Deviation of 1.62, downside deviation of 1.56, and Coefficient Of Variation of 1042.66. DexCom Inc technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm DexCom Inc treynor ratio, value at risk, downside variance, as well as the relationship between the maximum drawdown and potential upside to decide if DexCom Inc is priced favorably, providing market reflects its regular price of 73.54 per share.

DexCom Inc Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. DexCom middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for DexCom Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

DexCom Outstanding Bonds

DexCom issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. DexCom Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most DexCom bonds can be classified according to their maturity, which is the date when DexCom Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

DexCom Predictive Daily Indicators

DexCom intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of DexCom stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

DexCom Forecast Models

DexCom's time-series forecasting models are one of many DexCom's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary DexCom's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About DexCom Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how DexCom prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling DexCom shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as DexCom. By using and applying DexCom Stock analysis, traders can create a robust methodology for identifying DexCom entry and exit points for their positions.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DEXCOM INC operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2800 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding DexCom to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Bollinger Bands Now

   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Module

Complementary Tools for DexCom Stock analysis

When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies